Skip to main content
. 2016 Mar 3;98(3):579–587. doi: 10.1016/j.ajhg.2016.02.006

Table 1.

Clinical Features of 5 Individuals with ECCL in Whom an FGFR1 Mutation Was Detected

LR12-068 LR13-278 IN_0039 NIH_183 LR14-261
FGFR1 mutation c.1966A>G (p.Lys656Glu) c.1638C>A (p.Asn546Lys) c.1638C>A (p.Asn546Lys) c.1966A>G (p.Lys656Glu) c.1638C>A (p.Asn546Lys)
Mutation discovery method ES ES ES ES smMIP
Age at last assessment 7 y 15 y 17 m 2 y 8m 5 y
Gender M M M M F
Neurocognitive function normal delayed, in special skills class normal normal normal
Seizures no yes no no no
Intracranial lipomas yes yes yes no yes
Spinal lipomas no not assessed yes (T2/3 and L5/S1) no no
CNS Other Pilomyxoid/ pilocytic astrocytoma
WHO I
Tectal tumor, left temporal cortical dysplasia no Pilocytic/ pilomyxoid astrocytoma
WHO II
no
Nevus psiloliparus yes yes yes yes yes
Alopecia yes yes yes yes (right parietal) yes
Subcutaneous lipoma yes (fronto-temporal) yes yes (fronto-temporal) yes (parietal) yes
Focal scalp aplasia yes yes yes yes no
Skin tags yes (eyelid) yes yes yes (right eyelid, anterior to right ear) yes
Choristoma yes (bilateral) yes yes (right) no yes
Coloboma no yes (left upper eyelid) yes (left upper eyelid, iris and bilateral retinal) no (but segmental iris heterochromia present) no
Prior Publication no yes59 no yes8 yes60

Abbreviations are as follows: ES (exome sequencing) and mMIP (single molecule molecular inversion probes).